Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,467 people get STJ articles and Market Currents by email alert.

Get email alerts on STJ »

STJ

St. Jude Medical, Inc.

5/20/2013, 11:14 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 2, 2:56 PM St. Jude Medical, Inc. (STJ) declares $0.25/share quarterly dividend, in line with previous. Forward yield 2.46%. For shareholders of record June 28. Payable July 31. Ex-div date June 26. (PR) Comment! [Dividends]
Wednesday, April 17, 5:50 PM Volcano (VOLC) files a lawsuit against St. Jude Medical (STJ) for patent infringement, accusing STJ of violating its patent on certain guide wire methods used in its devices. The suit is just another salvo in an ongoing patent war between the two companies over pressure wire technology used their heart devices. The war actually began nearly three years ago, when STJ filed suit against VOLC for infringement of 5 of its own patents for pressure guide wire products. Comment! [Healthcare]
Wednesday, April 17, 8:20 AM From St. Jude's (STJ) earnings call. Lowers 2013 sales guidance to $5.36-5.48B, representing a cut of $107M at the midpoint. Analysts expect $5.7B. The lower forecast is due to changes in currency assumptions and a more cautious outlook in its cardiovascular business. Expects currency neutral sales growth of -1% to +2%. (Q1 earnings) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, April 17, 8:10 AM More on St. Jude Medical (STJ) Q1: net profit +5% to $223M, with the company enjoying a $21M tax benefit but taking $61M in charges, primarily related to restructuring and acquisition activities. Forex fluctuations hurt sales by $17M. Sales breakdown: Cardiac Rhythm Management -8% to $678M; Atrial Fibrillation +5% to $233M; total cardiovascular sales -2% to $328M. Expects Q2 EPS of $0.93-$0.95 vs consensus of 0.94 and FY EPS of $3.68-$3.73 vs $3.95. (PR) Comment! [Earnings]
Wednesday, April 17, 7:31 AM St. Jude Medical (STJ): Q1 EPS of $0.92 beats by $0.01. Revenue of $1.34B (-4% Y/Y) misses by $0.02B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, April 17, 12:05 AM Notable earnings before Wednesday’s open: ABT, ASML, BAC, BK, DGX, DOV, FCFS, HBAN, MAT, PNC, STJ, TXT Comment! [Earnings]
Tuesday, April 16, 5:30 PM Notable earnings before Wednesday’s open: ABT, ASML, BAC, BK, DGX, DOV, FCFS, HBAN, MAT, PNC, STJ, TXT Comment! [Earnings]
Friday, April 5, 5:00 AM St. Jude Medical (STJ) has been hit with lawsuits in California that allege that defects with the manufacturing and oversight of its now recalled Riata heart defibrillator "leads" injured or killed over 30 patients. The suits could have a wider impact, as they seek to get round a 2008 Supreme Court ruling that protected medical-device companies from product-liability claims as long as they complied with FDA standards. Comment! [Healthcare]
Friday, March 8, 2:55 PM St. Jude Medical (STJ +1.1%) is up today after the company reports the first patient implant in a new trial evaluating the company's Aplatzer Cardiac Plug, a device for the prevention of stroke. The trial is designed to determine if the device is safe and effective in preventing thrombus from migrating out of the left atrial appendage in patients with non-valvular atrial fibrillation who have a high risk for stroke. Comment! [Healthcare, On the Move]
Monday, February 25, 8:57 AM St. Jude Medical, Inc. (STJ) declares $0.25/share quarterly dividend, 9% increase from prior dividend of $0.23. Forward yield 2.43%. For shareholders of record Mar. 29. Payable Apr. 30. Ex-div date Mar. 27. (PR) Comment! [Dividends]
Friday, February 15, 2:10 PM St. Jude Medical (STJ -3.4%) has been working overtime to convince the Street that its Durata heart device leads are safe, but Cowen doesn't take the bait, downgrading the stock to Market Underperform over concerns that the new heart wire is no different from the ones already taken off the market. The firm cites a "significant risk" of a recall, which would " meaningfully damage" its defibrillator and pacemaker business. Comment! [Healthcare, On the Move]
Wednesday, February 13, 9:42 AM St. Jude Medical (STJ +0.5%) has issued a voluntary Class 1 recall of its Amplatzer TorqVue FX Delivery System, which is used for hole in the heart surgery, after the company discovered that the device could fracture in a number of cases, causing serious damage and even death. However, no serious injuries have occurred.
Comment! [Healthcare]
Wednesday, January 23, 9:04 AM More on St. Jude Medical (STJ +0.8%) Q4: net profit -4% to $120M despite cutting SG&A costs by 18% and R&D spending by 11%. Cardiac rhythm management sales -6% to $682M, atrial fibrillation products +10% to $239M, total cardiovascular sales flat at $338M. Expects Q1 EPS of $0.91-0.93 vs consensus of $0.89 and 2013 EPS of $3.68-3.73 vs $3.62. Comment! [Earnings, Healthcare]
Wednesday, January 23, 7:32 AM St. Jude Medical (STJ): Q4 EPS of $0.92 beats by $0.03. Revenue of $1.37B (-2% Y/Y) in-line. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, January 23, 12:05 AM Notable earnings before Wednesday’s open: ABBV, ABT, APD, ATI, BHI, CHKP, COH, DGX, FNFG, GD, LCC, MCD, MSI, NVS, PX, RES, SAP, STJ, TEL, TXT, UTX, WLP Comment! [Earnings]
Tuesday, January 22, 5:30 PM Notable earnings before Wednesday’s open: ABBV, ABT, APD, ATI, BHI, CHKP, COH, DGX, FNFG, GD, LCC, MCD, MSI, NVS, PX, RES, SAP, STJ, TEL, TXT, UTX, WLP Comment! [Earnings]

1
2
3
4
5
6
...
10
Next Page